The publications used in this paper were chosen based on the following inclusion criteria: publications between 2010 and 2023, performed on humans or cell cultures, focused on the effectiveness of anti-TNF drugs as a treatment regime for HS, as well as other remedies that have been shown to be more effective, and peer-reviewed experimental studies. Here, TNF is linked to histiocytic sarcoma.